Reme-D Inc.
PrivateLast Round
Early Funding
Jul 24, 2026
Total Funding Raised
$3.36M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reme-D Inc. is a biotechnology company that develops and manufactures affordable, room-temperature-stable molecular diagnostic kits for human and animal diseases in underserved regions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reme-D Inc. Comparables
Compare Reme-D Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vitrosens Biotechnology | 78% | |
| Rapidemic | 78% | |
| Molbio Diagnostics | 73% | |
Reme-D Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jul 24, 2026 | ||||
| Grant | Apr 8, 2026 | ||||
| Early Funding | Apr 2, 2026 | ||||
| Seed | Oct 1, 2025 | ||||
| Accelerator | Mar 14, 2024 | ||||
Grant | Mar 8, 2024 |
Reme-D Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Techstars | Accelerator |
| Ministry of Communications and Information Technology, Saudi Arabia | Grant |
| Global Innovation Fund | Early Funding |
| Africa Health Ventures | Early Funding |
| Misk Foundation | Grant |
| Oman Technology Fund | Seed |
| Bayer Cares Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
$1.45M raised led by Anara Impact Capital.
- Jun 18, 2026
Monthly visitors increased 815% MoM, reaching 2.4K.
Reme-D Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Reme-D Inc.'s valuation, stock price, and market status.